Research Center: Albert Einstein College of Medicine
Location: This is a virtual study in the United States
Lead Researchers: Dr. Jeffrey Gonzalez and Dr. Shivani Agarwal
IRB: This study has been reviewed and approved by the Albert Einstein Institutional Review Board IRB # 104631 & 2021-12789

Do you have type 1 diabetes and are looking for alternative ways to manage your blood sugar and improve your well-being? Join this virtual research study and be part of the future of diabetes care. Researchers from the Albert Einstein College of Medicine need your help in testing new care programs that could potentially enhance your emotional well-being and help you better control your diabetes.

If you qualify for this study, you may have the opportunity to access virtual care programs tailored to your mental and physical health needs. Your involvement may not only benefit you personally but also contribute to research that could transform diabetes care for many. Let’s advance the future of diabetes treatment together!

• Participants will be able to contribute to the development of future diabetes interventions at no cost.
• Participants may increase their knowledge about how to engage and retain young adults in diabetes research studies.
• Participants will be contributing valuable information that may benefit those with type 1 diabetes in the future.
• Participants will be helping to advance medical research.

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you can withdraw at any time.
• Any information that you provide will be kept strictly confidential, except as required by law.
• Qualified health professionals will monitor your health as it relates to the study.

• Men and women aged 18-64 who have been diagnosed with type 1 diabetes for 6 or more months
• Must be able to read, write, and speak in English or Spanish
• Must not be breastfeeding, pregnant, or planning to get pregnant in the next 12 months
• Must not have had a psychiatric hospitalization within the past 6 months
• Must not be currently participating in a clinical trial
• Must be able and willing to participate in the study virtually for approximately 12 months

The study team will explain the research in its entirety but some details are:

• Participants will be asked to sign a Preliminary Screening Consent Form to agree to the screening process and diagnostic interview, as the first screening step.
• Participants will be asked to complete the Universal Screening Questionnaire to determine basic eligibility for either study and a diabetes distress survey (“PAID”) before the diagnostic interview stage.
• Participants will be asked to schedule and undergo a diagnostic interview via Zoom with study staff to assess for co-morbid psychological conditions, which will determine their eligibility for The ReDUCe Study (diabetes distress) or The UP Study (anxiety and depression) or exclusion from both studies.

Albert Einstein College of Medicine
Albert Einstein College of Medicine is a research-intensive medical school. For more than 60 years, its diverse faculty and staff have set the standard for excellence in medical and graduate education and patient-centered clinical care, and have made major contributions to scientific research enhancing human health in its communities and beyond. Its mission is to prepare a diverse body of students to become knowledgeable, compassionate physicians and innovative scientific investigators, and to create new knowledge.